Pneumonia, Ventilator-Associated
60
6
7
30
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
15.0%
9 terminated out of 60 trials
76.9%
-9.6% vs benchmark
20%
12 trials in Phase 3/4
33%
10 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (60)
TRacheal Cuff PRessure Evaluation Study
The Efficacy of Adjuvant Oral Care in Prevention of Ventilator Associated Pneumonia.
BIS in ICU Interventional Study
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation
Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Patients With Hospital-acquired Pneumonia
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response
Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients
PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region
Biomarkers for Ventilator-associated Pneumonia
Immunity Markers in Intensive Care Patients and Ventilator-associated Pneumonia
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
Preoperative Optimization to Improve Functional Status
Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia
FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care Units
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
CTTI Risk Factors for HABP/VABP Study
Weekly Versus no Routine Ventilator Circuit Changes in NICU